iZafe Group (IZAFE-B) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Aug, 2026Executive summary
Net sales for Q2 2026 rose to 2,639 TSEK from 1,136 TSEK year-over-year, driven by increased demand but hampered by delayed installations and limited product availability.
Operating result (EBIT) was -7,511 TSEK, down from -4,277 TSEK, reflecting higher costs from organizational expansion and Dutch operations consolidation.
Focus for H2 2026 is on converting agreements and customer expansions into recurring revenues and improved cash flow.
Significant commercial steps in Sweden and the Netherlands, with new contracts and production ramp-up post-quarter.
Financial highlights
Net sales for Q2 2026: 2,639 TSEK (up from 1,136 TSEK year-over-year).
EBIT for Q2 2026: -7,511 TSEK (vs. -4,277 TSEK year-over-year).
EBITDA for Q2 2026: -5,862 TSEK (vs. -3,295 TSEK year-over-year).
Net result for Q2 2026: -7,418 TSEK (vs. -4,503 TSEK year-over-year).
Cash and cash equivalents at period end: 10,163 TSEK (vs. 825 TSEK year-over-year).
Outlook and guidance
Company maintains its forecast of 22.5 MSEK in annual recurring revenue (ARR) by end of 2026, requiring accelerated installations in H2.
Ongoing production and delivery of 1,300 new Dosell units expected to support ARR target.
Focus on shortening time from agreement to installation and increasing recurring revenues.
Latest events from iZafe Group
- Recurring revenues drive growth, with ARR at 10 MSEK and European expansion underway.IZAFE-B
Q4 2025 - Recurring revenues and major contracts drive strong growth outlook, despite ongoing losses.IZAFE-B
Q1 2026 - Recurring revenue model established, ARR at 10 MSEK, and Nordic expansion underway.IZAFE-B
Q3 2025 - Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-B
Q3 2025 - Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-B
Q2 2025 - Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-B
Q3 2024 - Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-B
Q2 2024 - Recurring revenues and international expansion drive improved results and future growth.IZAFE-B
Q1 2025 - Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-B
Q4 2024